ABN AMRO Investment Solutions Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$175M |
| 2 |
NVIDIA
NVDA
|
+$138M |
| 3 |
Microsoft
MSFT
|
+$137M |
| 4 |
Home Depot
HD
|
+$64.5M |
| 5 |
Eli Lilly
LLY
|
+$53.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$46.1M |
| 2 |
Equifax
EFX
|
+$23.6M |
| 3 |
FISV
Fiserv Inc
FISV
|
+$22.4M |
| 4 |
Ball Corp
BALL
|
+$22.3M |
| 5 |
Danaher
DHR
|
+$15.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.7% |
| 2 | Financials | 14.56% |
| 3 | Healthcare | 11.1% |
| 4 | Consumer Discretionary | 10.93% |
| 5 | Industrials | 9.17% |
Similar funds
ABN AMRO Investment Solutions's Q4 2025 Portfolio in Review
As of Q4 2025, ABN AMRO Investment Solutions held 580 positions worth $6.76B, up 38% from $4.88B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
ABN AMRO Investment Solutions deployed $1.78B of net new capital in Q4 2025, opening 147 new positions and adding to 305 existing holdings. Its largest new stake was ExxonMobil: 155,354 shares worth $18.7M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 34% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $46.1M trimmed.
- ABN AMRO Investment Solutions's largest Q4 2025 buy was ExxonMobil: 155,354 shares worth $18.7M.
- ABN AMRO Investment Solutions added most to Apple in Q4 2025, an estimated $175M increase.
- ABN AMRO Investment Solutions's biggest Q4 2025 reduction was Vertex Pharmaceuticals, cutting an estimated $46.1M.
- ABN AMRO Investment Solutions fully exited TotalEnergies in Q4 2025, selling an estimated $5.54M.
- ABN AMRO Investment Solutions's ten largest holdings make up 34% of its $6.76B portfolio in Q4 2025.
- ABN AMRO Investment Solutions opened 147 new positions and closed 16 in Q4 2025.
- ABN AMRO Investment Solutions's portfolio value rose 38% quarter-over-quarter to $6.76B.
Based on ABN AMRO Investment Solutions's 13F filing for Q4 2025, filed 6 Feb 2026.